In selected human tumors, including undifferentiated pleomorphic sarcoma, CSF3R expression, a neutrophil signature and neutrophil infiltration were associated with a type 1 immune response and better clinical outcome. This evidence concerns the gene CSF3R and undifferentiated pleomorphic sarcoma.